Clinical Trial Update: Study to Determine How BCX4161 is Metabolized and Eliminated by the Body [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating how BCX4161 is metabolized and eliminated in the human body for hereditary angioedema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• BCX4161

Snippet

Sponsor: BioCryst Pharmaceuticals | Conditions: Hereditary Angioedema | Phase 1 | Status: COMPLETED